1887

n Obstetrics and Gynaecology Forum - Bayer Schering Pharma - introduces a new paradigm in oral contraception with the launch of YAZ® : product news

Volume 19, Issue 3
  • ISSN : 1027-9148
USD

 

Abstract

Bayer Schering Pharma is proud to introduce YAZ®, the first low-dose drospirenone plus ethinylestradiol combination oral contraceptive in the optimised '24/4' regimen. YAZ® is the only oral contraceptive in South Africa with 3 registered indications; oral contraceptive; treatment of moderate acne vulgaris in women seeking oral contraception; treatment of premenstrual dysphoric disorder (PMDD) symptoms in women who have chosen oral contraception as their method of birth control.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/medog/19/3/EJC73339
2009-08-01
2016-12-11

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error